|
C21ORF91 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.192400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.97929999957003E-07 |
| Normal-vs-Stage2 |
2.13550000000007E-05 |
| Normal-vs-Stage3 |
3.016200E-01 |
| Normal-vs-Stage4 |
4.727700E-02 |
| Stage1-vs-Stage2 |
5.127200E-01 |
| Stage1-vs-Stage3 |
1.628620E-01 |
| Stage1-vs-Stage4 |
9.631600E-01 |
| Stage2-vs-Stage3 |
1.462800E-01 |
| Stage2-vs-Stage4 |
7.397200E-01 |
| Stage3-vs-Stage4 |
1.652630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.35169999993768E-07 |
| Normal-vs-AfricanAmerican |
1.421920E-02 |
| Normal-vs-Asian |
2.619900E-02 |
| Caucasian-vs-AfricanAmerican |
2.876600E-01 |
| Caucasian-vs-Asian |
8.963000E-01 |
| AfricanAmerican-vs-Asian |
8.001200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.005700E-02 |
| Normal-vs-Female |
1.750800E-01 |
| Male-vs-Female |
3.840600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.776400E-02 |
| Normal-vs-Extreme_Weight |
1.321480E-03 |
| Normal-vs-Obese |
7.695600E-01 |
| Normal-vs-Extreme_Obese |
7.71689999679026E-08 |
| Normal_Weight-vs-Extreme_Weight |
4.766800E-01 |
| Normal_Weight-vs-Obese |
3.917600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.729830E-02 |
| Extreme_Weight-vs-Obese |
2.513600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.014400E-02 |
| Obese-vs-Extreme_Obese |
7.935800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.429500E-02 |
| Normal-vs-Age(41-60Yrs) |
9.737400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.39959996317651E-09 |
| Normal-vs-Age(81-100Yrs) |
1.70189999981751E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.378200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.235850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.587800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.081800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.321600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.034400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.15250003879441E-09 |
| Normal-VS-Type2 PRCC |
8.370800E-01 |
| Normal-VS-KIRP CIMP |
7.901000E-01 |
| Normal-VS-Unclassified PRCC |
4.178100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.295400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.077400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.399590E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.876400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.659000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.253420E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.458400E-01 |
| Normal-vs-N1 |
5.719000E-01 |
| Normal-vs-N2 |
3.72210000000317E-05 |
| N0-vs-N1 |
5.310000E-01 |
| N0-vs-N2 |
9.791700E-02 |
| N1-vs-N2 |
2.183800E-01 |
|
|
